{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:55:34Z","timestamp":1791424534610,"version":"4.3.3"},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,9,13]]},"DOI":"10.18632\/oncotarget.10653","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T11:32:41Z","timestamp":1468841561000},"page":"59314-59321","source":"Crossref","is-referenced-by-count":55,"title":["Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma"],"prefix":"10.18632","volume":"7","author":[{"given":"Michele","family":"Carbone","sequence":"first","affiliation":[{"name":"Thoracic Oncology Program, University of Hawaii Cancer Center, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Queen Medical Center, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Napolitano","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Program, University of Hawaii Cancer Center, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Tanji","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Program, University of Hawaii Cancer Center, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey I.","family":"Pass","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, New York University, NYU Langone Medical Center, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Yang","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Program, University of Hawaii Cancer Center, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pastorino","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Program, University of Hawaii Cancer Center, Honolulu, HI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,7,18]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1179\/2049396712Y.0000000016","article-title":"Mesothelioma incidence in 50 states and the District of Columbia United States 2003-2008","volume":"19","author":"Eheman","year":"2013","journal-title":"Int J Occup Environ Health"},{"key":"2","volume-title":"United States Cancer Statistics: 1999-2012 Incidence and Mortality Web-based Report","author":"U S Cancer Statistics Working Group","year":"2015"},{"key":"3","doi-asserted-by":"publisher","first-page":"24A","DOI":"10.2471\/BLT.11.086678","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Sorahan","year":"2011","journal-title":"Bull World Health Organ"},{"key":"4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/(SICI)1097-4644(20000201)76:2<189::AID-JCB3>3.0.CO;2-J","article-title":"Simian virus 40 and human tumors: It is time to study mechanisms","volume":"76","author":"Carbone","year":"1999","journal-title":"J Cell Biochem"},{"key":"5","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1158\/0008-5472.CAN-04-0255","article-title":"Modern criteria to establish human cancer etiology","volume":"64","author":"Wong","year":"2004","journal-title":"Cancer Res"},{"key":"6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3816\/CLC.2003.n.031","article-title":"Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40","volume":"5","author":"Carbone","year":"2003","journal-title":"Clin Lung Cancer"},{"key":"7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/JTO.0000000000000506","article-title":"The Presence of Asbestos in the Natural Environment is Likely Related to Mesothelioma in Young Individuals and Women from Southern Nevada","volume":"10","author":"Carbone","year":"2015","journal-title":"J Thorac Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"13618","DOI":"10.1073\/pnas.1105887108","article-title":"Erionite exposure in North Dakota and Turkish villages with mesothelioma","volume":"108","author":"Steele","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jtho.2016.04.028","article-title":"Consensus Report of the 2015 Weinman International Conference on Mesothelioma","volume":"11","author":"Gavett","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1043\/1543-2165-133.8.1317","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group","volume":"133","author":"Litzky","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1700\/1660.18182","article-title":"Expression of thrombomodulin calretinin cytokeratin 5\/6 D2-40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma","volume":"100","author":"Messerini","year":"2014","journal-title":"Tumori"},{"key":"12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/oem.2005.023200","article-title":"The French National Mesothelioma Surveillance Program","volume":"63","author":"Astoul","year":"2006","journal-title":"Occup Environ Med"},{"key":"13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0140-6736(00)04013-7","article-title":"Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey","volume":"357","author":"Carbone","year":"2001","journal-title":"Lancet"},{"key":"14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrc2068","article-title":"A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes","volume":"7","author":"Baris","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"15","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Powers","year":"2011","journal-title":"Nat Genet"},{"key":"16","doi-asserted-by":"publisher","first-page":"e1005633","DOI":"10.1371\/journal.pgen.1005633","article-title":"Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s","volume":"11","author":"Baumann","year":"2015","journal-title":"PLoS Genet"},{"key":"17","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1038\/onc.2015.243","article-title":"Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma","volume":"35","author":"Dixit","year":"2016","journal-title":"Oncogene"},{"key":"18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Gaudino","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"19","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.molcel.2014.03.002","article-title":"Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O","volume":"54","author":"Affar el","year":"2014","journal-title":"Mol Cell"},{"key":"20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21 1 losses in malignant pleural mesothelioma","volume":"43","author":"Powell","year":"2011","journal-title":"Nat Genet"},{"key":"21","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","author":"Hasegawa","year":"2012","journal-title":"Cancer Sci"},{"key":"22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12253-013-9677-2","article-title":"BAP1 protein is a progression factor in malignant pleural mesothelioma","volume":"20","author":"Popper","year":"2014","journal-title":"Pathol Oncol Res"},{"key":"23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma","volume":"10","author":"Gaudino","year":"2015","journal-title":"J Thorac Oncol"},{"key":"24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1 NF2 CDKN2A and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Pass","year":"2015","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/JTO.0000000000000436","article-title":"Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study","volume":"10","author":"Scagliotti","year":"2015","journal-title":"J Thorac Oncol"},{"key":"26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Gustafson","year":"2016","journal-title":"Nat Genet"},{"key":"27","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/PAS.0000000000000394","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","volume":"39","author":"Churg","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"28","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.humpath.2015.06.024","article-title":"BAP1 facilitates diagnostic objectivity classification and prognostication in malignant pleural mesothelioma","volume":"46","author":"Krausz","year":"2015","journal-title":"Hum Pathol"},{"key":"29","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/modpathol.2015.87","article-title":"Loss of expression of BAP1 is a useful adjunct which strongly supports the diagnosis of mesothelioma in effusion cytology","volume":"28","author":"Gill","year":"2015","journal-title":"Mod Pathol"},{"key":"30","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cavazza","year":"2015","journal-title":"Mod Pathol"},{"key":"31","doi-asserted-by":"publisher","first-page":"e0150338","DOI":"10.1371\/journal.pone.0150338","article-title":"Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma","volume":"11","author":"Gill","year":"2016","journal-title":"PLoS One"},{"key":"32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.humpath.2015.12.012","article-title":"Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma","volume":"51","author":"Toon","year":"2016","journal-title":"Hum Pathol"},{"key":"33","doi-asserted-by":"crossref","first-page":"E182","DOI":"10.25011\/cim.v35i4.17146","article-title":"BAP1 is a good prognostic factor in advanced non-small cell lung cancer","volume":"35","author":"Shen","year":"2012","journal-title":"Clin Invest Med"},{"key":"34","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Begum","year":"2012","journal-title":"N Engl J Med"},{"key":"35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12967-014-0301-3","article-title":"Evaluation of clonal origin of malignant mesothelioma","volume":"12","author":"Powers","year":"2014","journal-title":"J Transl Med"},{"key":"36","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Lawrence","year":"2012","journal-title":"Cell"},{"key":"37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Moreira","year":"2015","journal-title":"Science"},{"key":"38","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"Cancer Genome Atlas Research","year":"2014","journal-title":"Nature"},{"key":"39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","author":"Cancer Genome Atlas Research","year":"2012","journal-title":"Nature"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2016.03.005","article-title":"Loss of expression of BAP1 is very rare in non-small cell lung carcinoma","author":"Gill","year":"2016","journal-title":"Pathology"},{"key":"41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesothelioma uveal and cutaneous melanoma and MBAITs","volume":"10","author":"Friedberg","year":"2012","journal-title":"J Transl Med"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T11:29:25Z","timestamp":1596713365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,18]]},"references-count":41,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2016,9,13]]}},"alternative-id":["10653","27447750"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10653","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,18]]}}}